P
Phyllis
Pfizer said it received new information last night about two cancer trails about the cardiovascular safety of Celebrex. The other one "revealed no greater cardiovascular risk than placebo."
Celebrex is approved for use in U.S> for the treatment of arthritis and pain. Pfizer has stood by the safety of its use since the Vioxx recall.
"These clinical trial results are new. The cardiovascular findings in one of the studies (APC) are unexpected and not consistent with the reported findings in the second study," the company said in a statement. "Pfizer is taking immediate steps to fully understand the results and rapidly communicate new information to regulators, physicians and patients around the world."
Celebrex is approved for use in U.S> for the treatment of arthritis and pain. Pfizer has stood by the safety of its use since the Vioxx recall.
"These clinical trial results are new. The cardiovascular findings in one of the studies (APC) are unexpected and not consistent with the reported findings in the second study," the company said in a statement. "Pfizer is taking immediate steps to fully understand the results and rapidly communicate new information to regulators, physicians and patients around the world."